Global Biopreservation Market

Global Biopreservation Market size was valued at US$ 4.15 Bn. in 2025 and the total revenue is expected to grow at 15.34% through 2026 to 2032, reaching nearly US$ 11.27 Bn by 2032.

The global Biopreservation market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Biopreservation report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report

Global Biopreservation Market Overview:

Biopreservation is the method of maintaining cells, tissues, or organs for long periods outside of their natural environment. Using lactic acid bacteria, this method is often used to preserve food and prolong its shelf life. Better access to quality healthcare and advanced technology products such as biopreservation facilities are expected to drive growth in healthcare spending, thus broadening the growth expectations.- It has proven to be an efficient long-term storage preservation technique. As a result, biopreservation has become critical for the success of a wide range of clinical and industrial applications of emerging cell-based technologies.

Global Biopreservation Market Dynamics:

Drivers:

During the forecast period, the rising life science market in all regions is expected to generate demand and drive the Biopreservation market. Advancements in the regenerative market and biobanking for treating and controlling several chronic diseases such as heart failure and diabetes and degenerative conditions affecting the nerves, bones, and joints are driving the biopreservation media market.

Large sums of money are being invested in cell therapy and regenerative medicine research by corporations, governments, and non-governmental organizations. The government's partnerships with companies and universities for better exposure to the technology used and its production for higher productivity are rising as healthcare expenditures rise year after the year leading to the growth of the biopreservation market.

As healthcare expenses increase year after year, the government's collaborations with companies and universities for better exposure to the technology used and its development for higher productivity is growing.

Restraints:

However, major issues of tissue or cell preservation and storage are major concerns with the transition from laboratory to market. Despite the defense, the freezing and thawing processes often trigger tissue or cell injury. This stifles the expansion of biopreservation's business potential. Tissue cryopreservation is much more complex and difficult than individual cell cryopreservation. The physicochemical and biophysical changes that occur during cryopreservation are linked to cell injuries during freezing and thawing. These processes might hinder market growth.

Global Biopreservation Market Segment Analysis:

Based on Product, the global biopreservation media and equipment market was dominated by the biopreservation media segment, in 2025. The growing research activities in stem cell therapy, regenerative medicine, and personalized medicine are responsible for the large share of this segment. Biopreservation media has been used extensively in stem cell therapy and the preservation of transplanted organs. Nutrient media have been widely used in tissue engineering, which involves stem cell storage. A continuous supply of oxygen and nutrition diffusion is needed in the early stages of stem cell culture. Bone defects have long been treated with stem cell engineering.

Based on Biospecimen, the global biopreservation media and equipment market was dominated by the human tissue samples segment, in 2025. The growing number of biobanks and R&D expenditure for life science research is responsible for this segment's large share.

Based on Application, Therapeutic Applications had the largest share of the market. The advances in the fields of regenerative medicine and personalized medicine, as well as the trend in cord blood banking, are all contributing to the segment's development. The high prevalence of chronic diseases around the world, as well as advances in treatment methods, account for the significant share of this segment.

Based on End Users, the biobanks segment is predicted to account for a significant portion of the industry. The growing preference for the preservation of stem cells, as well as the number of sperm and egg banks, account for the majority of this segment.

Global Biopreservation Market Regional Insights:

The demand for biopreservation media and equipment was dominated by North America, followed by Europe. Increased research activities in the field of regenerative medicine, rising R&D investment in life sciences research, and growing knowledge of personalized medicine are some of the major factors driving this market's development. This is due to the constant discovery of new drugs and the arrival of advanced therapies in the biomedical research sector. Moreover, the growing need for costly and better care for patients with chronic diseases and the constant discovery of new drugs, and the arrival of advanced therapies in the biomedical research sector are the major factors.

The demand for blood, solid tissue specimens, including paraffin-embedded or frozen bio-specimens of tumors, and other tissues (such as peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives) through numerous research institutes, pathological centers, and hospitals, are driving the North American industry. Favorable government regulations.

In the biopreservation media and equipment industry, Asia Pacific is projected to rise at the fastest pace. The increasing public and private investments in life sciences research, the number of biobanks and research centers, and the high prevalence of chronic diseases are all driving this market's growth.

The objective of the report is to present a comprehensive analysis of the global Biopreservation market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Biopreservation market dynamics, structure by analyzing the market segments and project the global Biopreservation market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Biopreservation market make the report investor’s guide.

Global Biopreservation Market Key Developments:

Global Biopreservation Market Scope: Inquire before buying

Global Biopreservation Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Biopreservation Market Key Players

1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. BioLife Solutions Inc.
4. Azenta US Inc.
5. Panasonic Corporation
6. MVE Biological Solutions
7. LabVantage Solutions Inc.
8. Taylor‑Wharton
9. PrincetonCryo / Princeton CryoTech Inc.
10. X‑Therma Inc.
11. Biomatrica Inc.
12. BioCision LLC
13. Avantor Inc.
14. ThermoGenesis Holdings Inc.
15. Bio‑Techne Corporation
16. Exact Sciences Corporation
17. Worthington Industries Inc.
18. Chart Industries Inc.
19. STEMCELL Technologies
20. Helmer Scientific Inc.
21. So‑Low Environmental Equipment Co.
22. AMS Biotechnology (AMSBIO)
23. OPS Diagnostics
24. Eppendorf AG
25. Sartorius AG
26. Cryoport Inc.
27. VWR International LLC (part of Avantor)
28. Sigma‑Aldrich Corporation (Merck subsidiary)
29. Cell Applications Inc
30. ZenBio

Frequently Asked Questions:

1. Which region has the largest share in Global Biopreservation Market?
Ans: North America region held the highest share in 2025.

2. What is the growth rate of Global Biopreservation Market?
Ans: The Global Biopreservation Market is growing at a CAGR of 15.34% during forecasting period.

3. What is scope of the Global Biopreservation market report?
Ans: Global Biopreservation Market report helps with the PESTEL, PORTER,  Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Biopreservation market?
Ans: The important key players in the Global Biopreservation Market are – Thermo Fisher Scientific Inc., Merck KGaA, Inc., ThermoGenesis Holdings Inc., Bio- Techne Corporation, Exact Sciences Corporation, BioLife Solutions Inc., Helman Scientific, Inc., Worthington Industries, Inc., Avantor, Inc., Chart Industries, Inc., Priceton Cryo Tech, Inc., BioCision LLC, and Other Key Players

5. What is the study period of this market?
Ans: The Global Biopreservation Market is studied from 2026 to 2032.